FDA-Device2021-05-12Class II
Programmers - Product Usage: used to treat arrhythmias related to bradycardia. Additionally, CRT-P devices can also provide cardiac resynchronization therapy (CRT) in treatment of heart failure. 1. 2090 Carelink 2. 29901 Encore
Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
Hazard
A longevity estimation error may occur in the early years of device life when a unipolar pacing vector is programmed in the right atrial (RA) lead and/or the right ventricular (RV) lead. No other device features or therapies are impacted.
Sold states
Worldwide distribution.
Affected count
37690 units
Manufactured in
8200 Coral Sea St Ne, N/A, Mounds View, MN, United States
Products
Programmers - Product Usage: used to treat arrhythmias related to bradycardia. Additionally, CRT-P devices can also provide cardiac resynchronization therapy (CRT) in treatment of heart failure. 1. 2090 Carelink 2. 29901 Encore
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-1527-2021Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief